Cargando…
Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches
The recent success of checkpoint blockade has highlighted the potential of immunotherapy approaches for cancer treatment. Although the majority of approved immunotherapy drugs target T cell subsets, it is appreciated that other components of the immune system have important roles in tumor immune sur...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838611/ https://www.ncbi.nlm.nih.gov/pubmed/27148271 http://dx.doi.org/10.3389/fimmu.2016.00152 |